Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Interventional Cardiology Devices Market By Product Type Balloons, Percutaneous Transluminal Coronary, Angioplasty Guide Wires, Stents, Catheters, Inferior Vena Cava Filters, Intravascular Ultrasound Systems, Left Atrial Appendage Devices and Others), By Disease Type, By End User and Region Forecast 2019-2030
Interventional cardiology devices market size was valued at US$ 14.9 billion in 2023 and is projected to reach a value of US$ 24.6 billion by 2030, at a CAGR of 8.9 from 2024-2030. Interventional cardiology deals with the treatment of various heart diseases by using intravascular catheter-based techniques. Interventional cardiology devices are commonly used in the treatment of coronary artery disease, conventional artery disease, and aneurysm. In this technique, catheter is inserted into any large peripheral artery or vein with the help of fluoroscopy by catheter whole procedure.
Interventional cardiology provides controlled bleeding and fast recovery within a short period of time and reduce the complications for patients. The most commonly used interventional cardiology devices include balloon-inflation devices, coronary stents, and cutting balloon catheters among others. Increase in the incidence rate of various cardiovascular diseases, a rise in preference for minimally invasive procedures, growing clinical trials for the novel interventional cardiology devices, and technological advancements of devices are anticipated to fuel the interventional cardiology market over the forecast period. Moreover, favourable reimbursement policies for the devices, lifestyle changes, and rise in product launchings might bolster the market. However, stringent regulatory policies, product recall, high cost for the manufacturing of interventional cardiology devices & treatments, and lack of skilled professionals are expected to dampen the market over the forecast period.
Furthermore, the increasing incidence of cardiovascular disease along with the growing healthcare expenditure in medical devices is expected to push the market growth in the forecasted years. In addition, the rise in tobacco consumption and the growing incidence of obesity is also expected to fuel the growth. Several government and non-government organizations including educational institutes and key market payers, have conducted public awareness campaigns to raise awareness regarding cardiac disease and its treatments. The advancement of technology and procedures in healthcare facilities like innovative cardiovascular devices and regulatory approvals are expected to fuel the growth of the market in the forecasted years. However, the huge cost of interventional cardiac devices and the availability of alternative cardiac disease treatments are expected to hinder the growth of the market in the forecasted years.
Study Period
2024-2030Base Year
2023CAGR
8.9%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Interventional cardiology devices market is growing at a significant CAGR owing to rise in demand for minimally invasive procedures and increase in the prevalence of various cardiac diseases around the globe. According to World Health Organization, approximately 17.3 Mn people died from CVDs in 2008 which is anticipated to reach 23.6 Mn by 2030. Most of the international players are focusing on innovation of novel products with minimally invasive procedures which are expected to upsurge the revenue of the market.
Moreover, acquisitions & mergers, collaborations, product approvals and launching, and patent filings are the strategies followed by the companies for dominating the market. For instance, in February 2017, Merit Medical Systems acquired interventional cardiology devices from the Argon Medical Devices and Catheter Connections, Inc. for strengthening its interventional cardiology devices portfolio. In addition, in January 2016, in Europe, Svelte Medical Systems launched Slender a sirolimus-eluting coronary stent system used as interventional cardiology device.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 14.9 billion |
Market Size in 2030 |
US$ 24.6 billion |
Market CAGR |
8.9% |
By Product Type |
|
By Disease Type |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global interventional cardiology devices market size was valued at US$ 14.9 billion in 2023 and is projected to grow at a CAGR of 8.9% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The interventional cardiology devices market ABIOMED Inc, ACIST Medical Systems, B. Braun Melsungen AG, Biotronik SE & Co., Boston Scientific Corporation, Cardinal Health
1.Executive Summary |
2.Global Interventional Cardiology Devices Market Introduction |
2.1.Global Interventional Cardiology Devices Market - Taxonomy |
2.2.Global Interventional Cardiology Devices Market - Definitions |
2.2.1.Product Type |
2.2.2.Disease Type |
2.2.3.End User |
2.2.4.Region |
3.Global Interventional Cardiology Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Interventional Cardiology Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Interventional Cardiology Devices Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Stents |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Catheters |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Inferior Vena Cava (IVC) Filters |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Intravascular Ultrasound Systems |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Left Atrial Appendage (LAA) Devices |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Others |
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
6.Global Interventional Cardiology Devices Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Congestive Heart Disease |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Percutaneous Valve Replacement |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Percutaneous Valve Repair |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Coronary Thrombectomy |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Interventional Cardiology Devices Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Cardiac Catheterization Labs |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Ambulatory Surgical Centres |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Interventional Cardiology Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons |
9.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires |
9.1.3.Stents |
9.1.4.Catheters |
9.1.5.Inferior Vena Cava (IVC) Filters |
9.1.6.Intravascular Ultrasound Systems |
9.1.7.Left Atrial Appendage (LAA) Devices |
9.1.8.Others |
9.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Congestive Heart Disease |
9.2.2.Percutaneous Valve Replacement |
9.2.3.Percutaneous Valve Repair |
9.2.4.Coronary Thrombectomy |
9.2.5.Others |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Clinics |
9.3.3.Cardiac Catheterization Labs |
9.3.4.Ambulatory Surgical Centres |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons |
10.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires |
10.1.3.Stents |
10.1.4.Catheters |
10.1.5.Inferior Vena Cava (IVC) Filters |
10.1.6.Intravascular Ultrasound Systems |
10.1.7.Left Atrial Appendage (LAA) Devices |
10.1.8.Others |
10.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Congestive Heart Disease |
10.2.2.Percutaneous Valve Replacement |
10.2.3.Percutaneous Valve Repair |
10.2.4.Coronary Thrombectomy |
10.2.5.Others |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Clinics |
10.3.3.Cardiac Catheterization Labs |
10.3.4.Ambulatory Surgical Centres |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons |
11.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires |
11.1.3.Stents |
11.1.4.Catheters |
11.1.5.Inferior Vena Cava (IVC) Filters |
11.1.6.Intravascular Ultrasound Systems |
11.1.7.Left Atrial Appendage (LAA) Devices |
11.1.8.Others |
11.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Congestive Heart Disease |
11.2.2.Percutaneous Valve Replacement |
11.2.3.Percutaneous Valve Repair |
11.2.4.Coronary Thrombectomy |
11.2.5.Others |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Clinics |
11.3.3.Cardiac Catheterization Labs |
11.3.4.Ambulatory Surgical Centres |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons |
12.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires |
12.1.3.Stents |
12.1.4.Catheters |
12.1.5.Inferior Vena Cava (IVC) Filters |
12.1.6.Intravascular Ultrasound Systems |
12.1.7.Left Atrial Appendage (LAA) Devices |
12.1.8.Others |
12.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Congestive Heart Disease |
12.2.2.Percutaneous Valve Replacement |
12.2.3.Percutaneous Valve Repair |
12.2.4.Coronary Thrombectomy |
12.2.5.Others |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Clinics |
12.3.3.Cardiac Catheterization Labs |
12.3.4.Ambulatory Surgical Centres |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Interventional Cardiology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons |
13.1.2.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires |
13.1.3.Stents |
13.1.4.Catheters |
13.1.5.Inferior Vena Cava (IVC) Filters |
13.1.6.Intravascular Ultrasound Systems |
13.1.7.Left Atrial Appendage (LAA) Devices |
13.1.8.Others |
13.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Congestive Heart Disease |
13.2.2.Percutaneous Valve Replacement |
13.2.3.Percutaneous Valve Repair |
13.2.4.Coronary Thrombectomy |
13.2.5.Others |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Clinics |
13.3.3.Cardiac Catheterization Labs |
13.3.4.Ambulatory Surgical Centres |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.ABIOMED Inc. |
14.2.2.ACIST Medical Systems |
14.2.3.B. Braun Melsungen AG |
14.2.4.Biotronik SE & Co. |
14.2.5.Boston Scientific Corporation |
14.2.6.Cardinal Health |
14.2.7.Edwards Lifesciences Corporation |
14.2.8.Johnson & Johnson Services Inc. |
14.2.9.Medtronic |
14.2.10.Merit Medical Systems |
14.2.11.Koninklijke Philips N.V. |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players